Updated:
U.S. Stem Cell, Inc.
U.S. Stem Cell, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001388319, and its reported industry is...
Overview
U.S. Stem Cell, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001388319, and its reported industry is Services-Commercial Physical & Biological Research. In 10-K filed on 2023-04-14, it reported annual revenue of USD 82,049; net income of USD -2,857,943; total assets of USD 68,039 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- U.S. Stem Cell, Inc.
- Former names in filing history
- BIOHEART, INC. (2007-02-13 to 2015-11-02)
- Classification
- Company
- Industry (SIC)
- 8731 — Services-Commercial Physical & Biological Research
- Headquarters
- Sunrise, FL, United States
- Incorporated in
- FL
- Fiscal year end
- December 31
- SEC CIK
- 0001388319
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $82,049 | -$2.9M | $68,039 | $5,133 | -$304,852 | |
| FY2021USD | $200,749 | -$3.3M | $50,999 | $39,393 | -$1.1M | |
| FY2020USD | $277,087 | -$2.9M | $88,152 | $18,570 | -$478,886 | |
| FY2019USD | $3.1M | -$3.8M | $89,843 | $0 | -$1.2M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-K | FORM 10-K | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-K/A | FORM 10-K/A | ||
| 10-Q | FORM 10-Q | ||
| 10-K | FORM 10-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-K | FORM 10-K | ||
| 10-Q | FORM 10-Q |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research U.S. Stem Cell, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.